MenQuadfi - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL

Reference details for licensed healthcare facility review and verification.

NDC 1149281-0590-10
Product NDC49281-0590
Generic Drug NameNEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
Brand NameMenQuadfi
ManufacturerSanofi Pasteur Inc.
Strength10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL
Dosage FormInjection
Drug TypeIntramuscular
Package Quantity10 Vial, Single-Dose
Package Description10 VIAL, SINGLE-DOSE in 1 CARTON (49281-590-10) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-590-58)
Active IngredientsNeisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen; Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen; Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen; Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen
Marketing CategoryBLA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection is tracked under NDC 49281-0590-10 and rolls up into product family 49281-0590. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 10 Vial, Single-Dose.
  • Manufacturer: Sanofi Pasteur Inc..
  • Dosage form: Injection.
  • Family size: 3 indexed presentations.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

MenQuadfi - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL, NDC 49281-0590-10, is a Sanofi Pasteur Inc. 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL injection presentation packaged as 10 Vial, Single-Dose.